Erden Banoglu

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 21

Top Venues

Gazi Üniversitesi

University of Iowa (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Gazi Üniversitesi Oct 07 2010

Turkey

Professor :: Pharmaceutical Chemistry

Education History

University of Iowa Aug 11 1993 - Aug 02 1997

United States

PHD :: Medicinal and Natural Products Chemistry

Gazi Üniversitesi Sep 15 1985 - Sep 12 1989

Turkey

BSC :: Pharmacy

Publications

Mustafa Emre Gedik, Ozge Saatci, Nathaniel Oberholtzer, Meral Uner, Ozge Akbulut-Caliskan, Metin Cetin, Mertkaya Aras, Kubra Ibis, Burcu Çalışkan, Erden Banoglu, Stefan Wiemann, Aysegül Uner, Sercan Aksoy, Shikhar Mehrotra, Özgür Sahin
Targeting TACC3 Induces Immunogenic Cell Death and Enhances T-DM1 Response in HER2-Positive Breast Cancer. Cancer research 84 (9) (2024)
Mustafa Emre Gedik, Ozge Saatci, Nathaniel Oberholtzer, Meral Uner, Ozge Akbulut-Caliskan, Metin Cetin, Mertkaya Aras, Kubra Ibis, Burcu Çalışkan, Erden Banoglu, Stefan Wiemann, Aysegül Uner, Sercan Aksoy, Shikhar Mehrotra, Özgür Sahin
Targeting TACC3 Induces Immunogenic Cell Death and Enhances T-DM1 Response in HER2-Positive Breast Cancer. Cancer research 84 (9) (2024)
Mustafa Emre Gedik, Ozge Saatci, Nathaniel Oberholtzer, Meral Uner, Ozge Akbulut-Caliskan, Metin Cetin, Mertkaya Aras, Kubra Ibis, Burcu Çalışkan, Erden Banoglu, Stefan Wiemann, Aysegül Uner, Sercan Aksoy, Shikhar Mehrotra, Özgür Sahin
Targeting TACC3 Induces Immunogenic Cell Death and Enhances T-DM1 Response in HER2-Positive Breast Cancer. Cancer research 84 (9) (2024)
Mustafa Emre Gedik, Ozge Saatci, Nathaniel Oberholtzer, Meral Uner, Ozge Akbulut-Caliskan, Metin Cetin, Mertkaya Aras, Kubra Ibis, Burcu Çalışkan, Erden Banoglu, Stefan Wiemann, Aysegül Uner, Sercan Aksoy, Shikhar Mehrotra, Özgür Sahin
Targeting TACC3 induces immunogenic cell death and enhances T-DM1 response in HER2-positive breast cancer. Cancer research (2024)
Mustafa Emre Gedik, Ozge Saatci, Nathaniel Oberholtzer, Meral Uner, Ozge Akbulut-Caliskan, Metin Cetin, Mertkaya Aras, Kubra Ibis, Burcu Çalışkan, Erden Banoglu, Stefan Wiemann, Aysegül Uner, Sercan Aksoy, Shikhar Mehrotra, Özgür Sahin
Targeting TACC3 Induces Immunogenic Cell Death and Enhances T-DM1 Response in HER2-Positive Breast Cancer. Cancer research 84 (9) (2024)
Mustafa Emre Gedik, Ozge Saatci, Nathaniel Oberholtzer, Meral Uner, Ozge Akbulut-Caliskan, Metin Cetin, Mertkaya Aras, Kubra Ibis, Burcu Çalışkan, Erden Banoglu, Stefan Wiemann, Aysegül Uner, Sercan Aksoy, Shikhar Mehrotra, Özgür Sahin
Targeting TACC3 induces immunogenic cell death and enhances T-DM1 response in HER2-positive breast cancer. Cancer research (2024)
Mustafa Emre Gedik, Ozge Saatci, Nathaniel Oberholtzer, Meral Uner, Ozge Akbulut-Caliskan, Metin Cetin, Mertkaya Aras, Kubra Ibis, Burcu Çalışkan, Erden Banoglu, Stefan Wiemann, Aysegül Uner, Sercan Aksoy, Shikhar Mehrotra, Özgür Sahin
Targeting TACC3 induces immunogenic cell death and enhances T-DM1 response in HER2-positive breast cancer. Cancer research (2024)
Abdurrahman Olgac, İrfan Çapan, Philipp Dahlke, Paul M Jordan, Oliver Werz, Erden Banoglu
Substituted 1,2,4-Triazoles as Novel and Selective Inhibitors of Leukotriene Biosynthesis Targeting 5-Lipoxygenase-Activating Protein. ACS omega 8 (34) (2023)
Tuğçe Gür Maz, Beyzanur Koc, Paul M Jordan, Kubra Ibis, Burcu Çalışkan, Oliver Werz, Erden Banoglu
Benzoxazolone-5-Urea Derivatives as Human Soluble Epoxide Hydrolase (sEH) Inhibitors. ACS omega 8 (2) (2023)
Tuğçe Gür Maz, Beyzanur Koc, Paul M Jordan, Kubra Ibis, Burcu Çalışkan, Oliver Werz, Erden Banoglu
Benzoxazolone-5-Urea Derivatives as Human Soluble Epoxide Hydrolase (sEH) Inhibitors. ACS omega 8 (2) (2023)
Sümeyye Turanlı, Esra Nalbat, Deniz Lengerli, Kubra Ibis, Sezen Güntekin Ergün, Ece Akhan Güzelcan, Mesut Muyan, Rengul Cetin-Atalay, Burcu Çalışkan, Erden Banoglu
Vicinal Diaryl-Substituted Isoxazole and Pyrazole Derivatives with In Vitro Growth Inhibitory and In Vivo Antitumor Activity. ACS omega 7 (41) (2022)
Deniz Lengerli, Kubra Ibis, Yahya Nural, Erden Banoglu
The 1,2,3-triazole 'all-in-one' ring system in drug discovery: a good bioisostere, a good pharmacophore, a good linker, and a versatile synthetic tool. Expert opinion on drug discovery (2022)
Erden Banoglu, Taner Ercanlı, Tuğçe Gür Maz, Daniela Vullo, Alessandro Bonardi, Paola Gratteri, Claudiu T Supuran
A Series of Thiadiazolyl-Benzenesulfonamides Incorporating an Aromatic Tail as Isoform-Selective, Potent Carbonic Anhydrase II/XII Inhibitors. ChemMedChem 17 (10) (2022)
Christian Kretzer, Paul M Jordan, Rossella Bilancia, Antonietta Rossi, Tuğçe Gür Maz, Erden Banoglu, Ulrich S Schubert, Oliver Werz
Shifting the Biosynthesis of Leukotrienes Toward Specialized Pro-Resolving Mediators by the 5-Lipoxygenase-Activating Protein (FLAP) Antagonist BRP-201. Journal of inflammation research 15 (2022)
İrfan Çapan, Paul M Jordan, Abdurrahman Olğaç, Burcu Çalışkan, Christian Kretzer, Oliver Werz, Erden Banoglu
Discovery and Optimization of Piperazine Urea Derivatives as Soluble Epoxide Hydrolase (sEH) Inhibitors. ChemMedChem 17 (12) (2022)
Sümeyye Turanlı, Azize Gizem Ergül, Paul M Jordan, Abdurrahman Olğaç, Burcu Çalışkan, Oliver Werz, Erden Banoglu
Quinazoline-4(3 H )-one-7-carboxamide Derivatives as Human Soluble Epoxide Hydrolase Inhibitors with Developable 5-Lipoxygenase Activating Protein Inhibition. ACS omega 7 (41) (2022)
Tuğçe Gür Maz, Sumeyye Turanlı, Huseyin Burak Caliskan, Burcu Çalışkan, Erden Banoglu
Development and molecular modeling studies of new thiadiazole piperazine urea derivatives as potential fatty acid amide hydrolase inhibitors. Archiv der Pharmazie 355 (8) (2022)
Betul Demir, Demet Cicek, Sedatcan Turkoglu, Neslihan Yuksel Bozdemir, Furkan Sarikurt, Erden Banoglu
Wood's lamp examination of hair and nails related to COVID-19 treatment. Dermatologic therapy 34 (6) (2021)
Ozge Akbulut-Caliskan, Deniz Lengerli, Ozge Saatci, Elif Duman, Urartu Özgür Şafak Şeker, Aynur Isik, Aytekin Akyol, Burcu Caliskan, Erden Banoglu, Özgür Sahin
A Highly Potent TACC3 Inhibitor as a Novel Anticancer Drug Candidate. Molecular cancer therapeutics 19 (6) (2020)
Abdurrahman Olgac, Andrea Carotti, Christian Kretzer, Stephanie Zergiebel, Andreas Seeling, Ulrike Garscha, Oliver Werz, Antonio Macchiarulo, Erden Banoglu
Discovery of Novel 5-Lipoxygenase-Activating Protein (FLAP) Inhibitors by Exploiting a Multistep Virtual Screening Protocol. Journal of chemical information and modeling 60 (3) (2020)
Suhaib Shekfeh, Burcu Çalışkan, Katrin Fischer, Tansu Yalçın, Ulrike Garscha, Oliver Werz, Erden Banoglu
A Multi-step Virtual Screening Protocol for the Identification of Novel Non-acidic Microsomal Prostaglandin E2 Synthase-1 (mPGES-1) Inhibitors. ChemMedChem 14 (2) (2018)

Erden Banoglu.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Erden Banoglu